AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163U956. A total of 3 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $39,000 | +387.5% | 4,100 | +310.0% | 0.00% | – |
Q2 2020 | $8,000 | -50.0% | 1,000 | -61.5% | 0.00% | – |
Q1 2020 | $16,000 | -94.7% | 2,600 | -89.6% | 0.00% | -100.0% |
Q4 2019 | $303,000 | +114.9% | 24,900 | +104.1% | 0.00% | +100.0% |
Q3 2019 | $141,000 | -20.3% | 12,200 | -31.1% | 0.00% | -50.0% |
Q2 2019 | $177,000 | -21.0% | 17,700 | +1.7% | 0.00% | 0.0% |
Q1 2019 | $224,000 | -25.8% | 17,400 | -12.6% | 0.00% | -33.3% |
Q4 2018 | $302,000 | +93.6% | 19,900 | +148.8% | 0.00% | +200.0% |
Q2 2018 | $156,000 | -71.6% | 8,000 | -70.7% | 0.00% | -83.3% |
Q1 2018 | $550,000 | +45.5% | 27,300 | -4.2% | 0.01% | +100.0% |
Q4 2017 | $378,000 | -68.9% | 28,500 | -56.7% | 0.00% | -72.7% |
Q3 2017 | $1,214,000 | -10.9% | 65,800 | -11.2% | 0.01% | -21.4% |
Q2 2017 | $1,363,000 | +13.0% | 74,100 | +38.5% | 0.01% | 0.0% |
Q1 2017 | $1,206,000 | +40100.0% | 53,500 | +53400.0% | 0.01% | – |
Q4 2016 | $3,000 | -94.1% | 100 | -95.2% | 0.00% | -100.0% |
Q3 2016 | $51,000 | -37.0% | 2,100 | -38.2% | 0.00% | 0.0% |
Q2 2016 | $81,000 | -62.8% | 3,400 | -63.4% | 0.00% | -66.7% |
Q1 2016 | $218,000 | -51.2% | 9,300 | -37.2% | 0.00% | -40.0% |
Q4 2015 | $447,000 | +13.7% | 14,800 | +49.5% | 0.01% | 0.0% |
Q3 2015 | $393,000 | -35.4% | 9,900 | +12.5% | 0.01% | -44.4% |
Q2 2015 | $608,000 | +553.8% | 8,800 | +417.6% | 0.01% | +800.0% |
Q1 2015 | $93,000 | +615.4% | 1,700 | +466.7% | 0.00% | – |
Q4 2014 | $13,000 | -59.4% | 300 | -70.0% | 0.00% | – |
Q3 2014 | $32,000 | -71.4% | 1,000 | -81.5% | 0.00% | -100.0% |
Q2 2014 | $112,000 | +314.8% | 5,400 | +285.7% | 0.00% | – |
Q1 2014 | $27,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|